SCHEMBL31094979

SCHEMBL31094979

CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 4/20 0.48
▸ NPY1R P25929 3/20 0.48
▸ NPY2R P49146 3/20 0.48
▸ FOLH1 Q04609 4/20 0.45
▸ DPP8 Q6V1X1 2/20 0.43
▸ DPP9 Q86TI2 2/20 0.43
▸ NOD1 Q9Y239 1/20 0.43
▸ DPP4 P27487 1/20 0.43
▸ GSR P00390 1/20 0.42
▸ ERAP2 Q6P179 1/20 0.41
▸ ERAP1 Q9NZ08 1/20 0.41
▸ LNPEP Q9UIQ6 1/20 0.41
▸ DPP7 Q9UHL4 1/20 0.41
▸ NPY5R Q15761 2/20 0.41
▸ NTSR2 O95665 1/20 0.41
▸ NTSR1 P30989 1/20 0.41
▸ BACE1 P56817 2/20 0.41
▸ NMT2 O60551 1/20 0.41
▸ NMT1 P30419 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31343260 0.95 NPY4R (0.51) NPY4RNPY1RNPY2RFOLH1NOD1
SCHEMBL30388451 0.95 NPY4R (0.51) NPY4RNPY1RNPY2RFOLH1NOD1
SCHEMBL29679789 0.95 FOLH1 (0.48) NPY4RNPY1RNPY2RFOLH1DPP8
SCHEMBL29630455 0.93 NPY4R (0.47) NPY4RNPY1RNPY2RFOLH1DPP8
SCHEMBL29680077 0.93 FOLH1 (0.51) NPY4RNPY1RNPY2RFOLH1NOD1
SCHEMBL30286850 0.93 FOLH1 (0.51) NPY4RNPY1RNPY2RFOLH1BACE1
SCHEMBL29590481 0.92 NPY4R (0.48) NPY4RNPY1RNPY2RFOLH1NOD1
SCHEMBL29679551 0.92 NMT2 (0.46) NPY4RNPY1RNPY2RFOLH1NOD1
SCHEMBL31375133 0.91 FOLH1 (0.55) NPY4RNPY1RNPY2RFOLH1DPP8
SCHEMBL30527857 0.91 FOLH1 (0.55) NPY4RNPY1RNPY2RFOLH1DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240272146-A1 CHROMOGENIC AND FLUOROGENIC COMPOUNDS AND THEIR USE FOR BIOLOGICAL DETECTION AAT BIOQUEST, INC. 2024-08-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240272146-A1 CHROMOGENIC AND FLUOROGENIC COMPOUNDS AND THEIR USE FOR BIOLOGICAL DETECTION ANTXR2, CDYL, VIP NPY4R 945/4885NPY1R 571/4885NPY2R 1029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback